Increased Circulating Betatrophin Concentrations in Patients with Type 2 Diabetes
Betatrophin has recently been described as a key hormone to stimulate beta-cell mass expansion in response to insulin resistance and obesity in mice. The finding has generated an interest in the development of antidiabetic drugs with betatrophin as the active component. However, the circulating leve...
Saved in:
Main Authors: | Daniel Espes, Mats Martinell, Per-Ola Carlsson |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | International Journal of Endocrinology |
Online Access: | http://dx.doi.org/10.1155/2014/323407 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Circulating Levels of Betatrophin and Irisin Are Not Associated with Pancreatic β-Cell Function in Previously Diagnosed Type 2 Diabetes Mellitus Patients
by: Lingshu Wang, et al.
Published: (2016-01-01) -
The Increased Circulating Plasma Levels of Vascular Endothelial Growth Factor in Patients with Type 1 Diabetes Do Not Correlate to Metabolic Control
by: Kailash Singh, et al.
Published: (2017-01-01) -
Moderate-Intensity Exercise and Musical Co-Treatment Decreased the Circulating Level of Betatrophin
by: Hendra Susanto, et al.
Published: (2020-01-01) -
Betatrophin Acts as a Diagnostic Biomarker in Type 2 Diabetes Mellitus and Is Negatively Associated with HDL-Cholesterol
by: Min Yi, et al.
Published: (2015-01-01) -
Increased Circulating Chemerin in Relation to Chronic Microvascular Complications in Patients with Type 2 Diabetes
by: Ping Gu, et al.
Published: (2019-01-01)